319 related articles for article (PubMed ID: 25139386)
1. [Medicines for children and "off-label use" 5 years after implementation of the Paediatric Regulation (EC) No 1901/2006. An interim analyis].
Afentaki A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Sep; 57(9):1111-9. PubMed ID: 25139386
[TBL] [Abstract][Full Text] [Related]
2. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
[TBL] [Abstract][Full Text] [Related]
3. Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.
Schröder C; Dörks M; Kollhorst B; Blenk T; Dittmann RW; Garbe E; Riedel O
Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):413-420. PubMed ID: 27623818
[TBL] [Abstract][Full Text] [Related]
4. Drug utilization and off-label drug use among Spanish emergency room paediatric patients.
Morales-Carpi C; Estañ L; Rubio E; Lurbe E; Morales-Olivas FJ
Eur J Clin Pharmacol; 2010 Mar; 66(3):315-20. PubMed ID: 19936729
[TBL] [Abstract][Full Text] [Related]
5. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
[TBL] [Abstract][Full Text] [Related]
6. Paediatric off-label and unlicensed prescribing in primary care in Malta: Prospective observational drug utilisation study.
Ellul IC; Grech V; Attard-Montalto S
Int J Risk Saf Med; 2015; 27(3):123-34. PubMed ID: 26410246
[TBL] [Abstract][Full Text] [Related]
7. Off-label paediatric drug use in an Indonesian community setting.
Abdulah R; Khairinisa MA; Pratiwi AA; Barliana MI; Pradipta IS; Halimah E; Diantini A; Lestari K
J Clin Pharm Ther; 2015 Aug; 40(4):409-12. PubMed ID: 25884353
[TBL] [Abstract][Full Text] [Related]
8. Marked reductions in outpatient antibiotic prescriptions for children and adolescents - a population-based study covering 83% of the paediatric population, Germany, 2010 to 2018.
Holstiege J; Schulz M; Akmatov MK; Steffen A; Bätzing J
Euro Surveill; 2020 Aug; 25(31):. PubMed ID: 32762794
[TBL] [Abstract][Full Text] [Related]
9. [Off-label drug prescriptions among outpatient children and adolescents in Germany--a database analysis].
Sonntag D; Trebst D; Kiess W; Kapellen T; Bertsche T; Kostev K
Dtsch Med Wochenschr; 2013 Oct; 138(44):2239-45. PubMed ID: 24150699
[TBL] [Abstract][Full Text] [Related]
10. Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care--a nationwide study.
Olsson J; Kimland E; Pettersson S; Odlind V
Acta Paediatr; 2011 Sep; 100(9):1272-5. PubMed ID: 21438922
[TBL] [Abstract][Full Text] [Related]
11. Off-label use of prescription drugs in childhood and adolescence: an analysis of prescription patterns in Germany.
Mühlbauer B; Janhsen K; Pichler J; Schoettler P
Dtsch Arztebl Int; 2009 Jan; 106(3):25-31. PubMed ID: 19564959
[TBL] [Abstract][Full Text] [Related]
12. Changes in anticonvulsant prescribing for Australian children: implications for Quality Use of Medicines.
Cohen SA; Lawson JA; Graudins LV; Pearson SA; Gazarian M
J Paediatr Child Health; 2012 Jun; 48(6):490-5. PubMed ID: 22050665
[TBL] [Abstract][Full Text] [Related]
13. Off-label drug use among hospitalised children: identifying areas with the highest need for research.
Hsien L; Breddemann A; Frobel AK; Heusch A; Schmidt KG; Läer S
Pharm World Sci; 2008 Oct; 30(5):497-502. PubMed ID: 18219585
[TBL] [Abstract][Full Text] [Related]
14. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
15. Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches.
Carnovale C; Conti V; Perrone V; Antoniazzi S; Pozzi M; Merlino L; Venegoni M; Clementi E; Radice S
Eur J Pediatr; 2013 Dec; 172(12):1679-85. PubMed ID: 23913312
[TBL] [Abstract][Full Text] [Related]
16. The impact of legislation on drug substances used off-label in paediatric wards--a nationwide study.
Haslund-Krog S; Mathiasen R; Christensen HR; Holst H
Eur J Clin Pharmacol; 2014 Apr; 70(4):445-52. PubMed ID: 24398969
[TBL] [Abstract][Full Text] [Related]
17. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
[TBL] [Abstract][Full Text] [Related]
18. Paediatric off-label use of drugs in Gansu, China: a multicentre cross-sectional study.
Meng M; Ge B; Lei W; Wu Y; Tian M; Lu Y; Shao T; Yang Y; Luo X; Luo J; Gao Y; Li Q; Chen Y
BMJ Open; 2024 May; 14(5):e078126. PubMed ID: 38740506
[TBL] [Abstract][Full Text] [Related]
19. More medicines for children: impact of the EU paediatric regulation.
Nordenmalm S; Tomasi P; Pallidis C
Arch Dis Child; 2018 Jun; 103(6):557-564. PubMed ID: 29490933
[TBL] [Abstract][Full Text] [Related]
20. Off-label prescribing to children in the United States outpatient setting.
Bazzano AT; Mangione-Smith R; Schonlau M; Suttorp MJ; Brook RH
Acad Pediatr; 2009; 9(2):81-8. PubMed ID: 19329098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
